TF Name |
Cell-line |
Condition/Source |
Collections |
Species |
Identifiers |
JASPAR ID |
NR3C1 |
MEF (mouse embryonic fibroblasts) |
Treatment: Dexamethasone 100 nM for 1 hr; Genotype: knockout of endogenous GR; |
Permissive
|
Mus musculus |
GSE108634
...
|
MA0113.3
|
NR3C1 |
MEF (mouse embryonic fibroblasts) |
Treatment: Dexamethasone 100 nM for 1 hr; Genotype: knockout of endogenous GR, stably expressing GFP-GR; |
Permissive
|
Mus musculus |
GSE108634
...
|
MA0113.3
|
NR3C1 |
MEF (mouse embryonic fibroblasts) |
Treatment: no treatment; Genotype: knockout of endogenous GR, stably expressing P481R GFP-GRtetra; |
Permissive
|
Mus musculus |
GSE108634
...
|
MA0113.3
|
NR3C1 |
MEF (mouse embryonic fibroblasts) |
Treatment: Dexamethasone 100 nM for 1 hr; Genotype: knockout of endogenous GR, stably expressing P481R GFP-GRtetra; |
Permissive
Robust
|
Mus musculus |
GSE108634
...
|
MA0113.3
|
NR3C1 |
BWTG3(Hepatocellular carcinoma of the mouse) |
Treatment: none; |
Permissive
|
Mus musculus |
GSE123953
...
|
MA0113.3
|
NR3C1 |
BWTG3(Hepatocellular carcinoma of the mouse) |
Treatment: 1uM Dex (Sigma, D-2915) for 3 hrs; |
Permissive
Robust
|
Mus musculus |
GSE123953
...
|
MA0113.3
|
NR3C1 |
BWTG3(Hepatocellular carcinoma of the mouse) |
Treatment: 1uM Dex (Sigma, D-2915) and 1000u/ml recombinant TNF for 3 hrs; |
Permissive
|
Mus musculus |
GSE123953
...
|
MA0113.3
|
NR3C1 |
BWTG3(Hepatocellular carcinoma of the mouse) |
Treatment: 1000u/ml recombinant TNF for 3 hrs; |
Permissive
|
Mus musculus |
GSE123953
...
|
MA0113.3
|
NR3C1 |
IMR90 (lung fibroblasts) |
GLUCC |
Permissive
Robust
|
Homo sapiens |
ERP007081
|
MA0113.3
|
NR3C1 |
K562 (myelogenous leukemia) |
GLUCC |
Permissive
|
Homo sapiens |
ERP007081
|
MA0113.3
|
Showing 10 records in page 18
from 23 pages